BOOTHBAY FUND MANAGEMENT, LLC - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 75 filers reported holding VISTAGEN THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
BOOTHBAY FUND MANAGEMENT, LLC ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$95,000
+6.7%
76,351
+66.5%
0.00%0.0%
Q4 2021$89,000
-44.0%
45,864
-20.8%
0.00%
-50.0%
Q3 2021$159,000
-60.3%
57,916
-54.5%
0.00%
-69.2%
Q2 2021$401,000
-37.4%
127,418
-57.6%
0.01%
-45.8%
Q1 2021$641,000
-29.3%
300,717
-35.7%
0.02%
-29.4%
Q4 2020$907,000467,4360.03%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 11,728,033$32,135,00011.34%
VR Adviser, LLC 16,047,286$43,970,0005.65%
COMMODORE CAPITAL LP 5,123,509$14,038,0003.70%
Ghost Tree Capital, LLC 2,000,000$5,480,0001.60%
EPIQ PARTNERS, LLC 916,100$2,510,0001.16%
SILVERARC CAPITAL MANAGEMENT, LLC 707,733$1,939,0001.10%
SPHERA FUNDS MANAGEMENT LTD. 3,824,938$10,480,0000.88%
HighVista Strategies LLC 438,239$1,201,0000.80%
Nicholas Investment Partners, LP 2,786,354$7,635,0000.56%
NEA Management Company, LLC 16,302,596$44,669,0000.53%
View complete list of VISTAGEN THERAPEUTICS INC shareholders